Antithrombotic agents' use in patients with atrial fibrillation and acute cerebral ischemia

Journal of Neurology

Volumn 253, Issue 8, 2006, Pages 1076-1082

  Cordonnier, Charlotte ^a   Leys, Didier ^a   Deplanque, Dominique ^a   Hénon, Hilde ^a  

^a UNIV LILLE   (France)

Author keywords

Anticoagulation; Antiplatelet drugs; Antithrombotic drugs; Audit; Ischemic stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BARTHEL INDEX; BLEEDING; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG UTILIZATION; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; EVIDENCE-BASED MEDICINE; FEMALE; FIBRINOLYTIC AGENTS; GUIDELINE ADHERENCE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MEDICAL RECORDS; MIDDLE AGED; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 33748974080     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0176-7     Document Type: Article

References (28)

1. Al-Sadat A, Sunbulli M, Chaturvedi S (2002) Use of intravenous heparin by North American Neurologists Do the data matter. Stroke 33:1574-1577
2. Albers G, Bittar N, Young L, hattemer CR, Gandhi AJ, Kemp SM, Hall EA, Morton DJ, Yim J, Vlasses PH (1997) Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals. Neurology 48:1598-1604
3. Andersen D (1993) How twin cities neurologists treat ischemic stroke? Policies and trends. Arch Neurol. 50:1098-1103
4. Ardern-Holmes S, Raman R, Anderson NE, Charleston AJ, Bennet R (1999) Opinion of New Zealand physicians on management of acute stroke: results of a national survey. Aust N Z J Med. 29:324-330
5. Bath P, Lindenstrom E, Boysen G, De Deyn P, Friis P, Leys D, Marttila R, Olsson J, O'Neill D, Orgogozo J, Ringelstein B, van der Sande J, Turpie AG (2001) Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet 358:702-710
6. Berge E, Abdelnoor M, Nakstad PH, Sandset PM (2000) Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group Heparin in Acute Embolic Stroke Trial. Lancet 355:1205-1210
7. Brass L, Lichtman JH, Ceres J, Krumholz HM (1998) Management of stroke among academic medical centers. Stroke 29:312
8. CAST CASTCG (1997) CAST: randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 349:1641-1649
9. Chen Z, Sandercock P, Pan HC, Counsell C, Collins R, Liu LS, Xie JX, Warlow C, Peto R (2000) Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40,000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke 31:1240-1249
10. Cordonnier C, Girot M, Dorp E, Rimetz P, Bouillaguet S, Henon H, Lucas C, Godefroy O, Leys D (2000) Stroke units from scientific evidence to practice: the experience of the Lille stroke unit. Cerebrovasc Dis. 10:17-20
11. Coull B, Williams LS, Goldstein LB, Meschia JF,Heitzman D, Chaturvedi S, Johnston KC, Starkman S, Morgenstern LB, Wilterdink JL, Levine SR, Saver JL (2002) Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (A Division of the American Heart Association). Stroke 33:1934-1942
12. Daffertshofer M, Grips E, Dempfle CE, Hennerici M (2003) Heparin in der Akutphase des ischämischen Schlaganfalls. Datenlage une klinische Realität. Nervenartz 74:307-319
13. Diener H, Ringelstein EB, von Kummer R, Langohr HD, Bewermeyer H, Landgraf H, Hennerici M, Welzel D, Grave M, Brom J, Weidinger G (2001) Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin. Results of the TOPAS Trial. Stroke 32:22-29
14. Duke R, Bloch FG, Turpie AG, Trebilcock R, Bayer N (1986) Intravenous heparin for the prevention of stroke progression in acute partial stable stroke: a randomized controlled trial. Ann Intern Med 105:825-828
15. Easton J, Albers GW, Caplan LR, Saver JL,Sherman DG for the TIA Working Group (2004) Reconsideration of TIA terminology and definitions. Neurology 62:S29-S34
16. European Stroke Council ENSaEFoNS (2000) European Stroke Initiative recommendations for stroke management. Cerebrovasc Dis. 10:335-351
17. Ferro J (2003) Cardioembolic stroke: an update. Lancet Neurology 2:177-188
18. Hack W, Kaste M, Bogousslavsky J, Brainin M, Chamorro A, Lees K, Kwiecinski H, Toni P, Langhorne P, Diener C, Hennerici M, Ferro J, Sivenius J, Gunnar N, Bath P, Olsen TS, Gugging M European Stroke Initiative Executive Committee, the EUSI Writing Committe (2003) European Stroke Initiative Recommendations for Stroke Management-update 2003. Cerebrovasc Dis 16:311-337
19. Hart R, Palacio S, Pearce LA (2002) Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials. Stroke 33:2722-2727
20. Hommel M, FISS bis Investigators Group (1998) Fraxiparine in Ischemic Stroke Study (FISS bis). Cerebrovasc Dis 8:19A. Abstract
21. Investigators PCftToOiASTT (1998) Low molecular weight heparinoid, ORG 10172 (Dsanaparoid), and outcome after acute ischemic stroke JAMA 279:1265-1272
22. IST IST, Collaborative Group (1997) The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet 349:1569-1581
23. Kay R, Wong KS, Yu YL, Chan YW, Tsoi TH, Ahuja AT, Chan FL, Fong KY, Law CB, Wong A (1995) Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med. 333:1588-1593
24. Kraywinkel K, Weimar C, Busse O, Haass A-J, Ehrenfeld CE, Diener HC, für den Studienverbund Schlaganfall (2004) Practice of anticoagulation with heparin following acute stroke in Germany - Results from 10 centers of the German Stroke Study Collaboration. Akt Neurologie 31:383-388
25. Marsh Er, Adams HP Jr, Biller J, Wasek P, Banwart K, Mitchell V, Woolson R (1989) Use of antithrombotic drugs in the treatment of acute ischemic stroke: a survey of neurologists in practice in the United States. Neurology 39:1631-1634
26. Niclot P (2001) Enquête en ligne La lettre du neurologue 8:365
27. Saxena R, Lewis S, Berge E, Sandercock PAG, Koudstaak PJ, for the International Stroke Trial Collaborative Group (2001) Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke 32:2333-2337
28. Schmidt W, Heuschmann P, Taeger D, Henningsen H, Buecker-Nott HJ, Berger K (2004) Determinants of IV heparin treatment in patients with ischemic stroke. Neurology 63:2407-2409